PPP1R14A and glioblastoma: In addition, PPP1R14A was also evaluated for changes in the degree of methylation and the possibility of becoming tumor markers in other cancers, such as GBM, HNSC, and CRC (Bouras et al., 2019; Butler et al., 2020; Kanazawa et al., 2019; Li et al., 2017).